Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income -577.36 K-763.87 K-867.83 K-376.14 K-315.96 K-1.88 M -3.44 M Non-Operating Income, Total 1.12 M1.13 M392.61 K240.05 K221.76 K226.14 K 1.08 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 1.12 M1.13 M392.61 K240.05 K221.76 K226.14 K 1.08 M Unusual income/expense —————— — Pretax income 542.33 K362.58 K-475.22 K-136.09 K-94.19 K-1.65 M -2.36 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 542.33 K362.58 K-475.23 K-136.09 K-94.19 K-1.65 M -2.36 M Discontinued operations —————— — Net income 542.33 K362.58 K-475.23 K-136.09 K-94.19 K-1.65 M -2.36 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 542.33 K362.58 K475.23 K-1.09 M94.19 K1.65 M 1.13 M Basic earnings per share (Basic EPS) 0.120.12-0.05-0.030.030.57 — Diluted earnings per share (Diluted EPS) 0.120.12-0.050.120.030.57 — Average basic shares outstanding 26.42 M32.84 M6.42 M18.98 M10.9 M10.9 M — Diluted shares outstanding 16.42 M16.42 M9.42 M12.7 M10.9 M10.9 M — EBITDA —————— — EBIT -577.36 K-763.87 K-867.83 K-376.14 K-315.96 K-1.88 M -3.44 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —